Clinical Trial Update: A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A first-in-human study of 3H-10000 in patients with unresectable or metastatic solid tumors is currently in Phase 1/Phase 2 and actively recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Stomach Cancer

Drugs mentioned

• 3H-10000

Snippet

Sponsor: 3H Pharmaceuticals Co., Ltd. | Conditions: Lung Cancer, Stomach Cancer | Phase 1, Phase 2 | Status: RECRUITING